Current Report Filing (8-k)
May 09 2019 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
May 9, 2019
SENSUS
HEALTHCARE, INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
|
001-37714
|
|
27-1647271
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
851 Broken
Sound Pkwy., NW # 215, Boca Raton, Florida
|
|
33487
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including
area code:
(561) 922-5808
_________________________________________________
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
x
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
|
SRTS
|
|
Nasdaq Stock Market, LLC
|
Warrants to Purchase Common Stock (exp. June 8, 2019)
|
|
SRTSW
|
|
Nasdaq Stock Market, LLC
|
SENSUS HEALTHCARE, INC.
FORM 8-K
CURRENT REPORT
|
Item 2.02
|
Results of Operation and Financial Condition
|
On May 9,
2019, Sensus Healthcare, Inc. (the “Registrant”) announced via press release the Registrant’s financial results
for the first quarter of 2019. A copy of the Registrant’s press release is included herein as Exhibit 99.1 and incorporated
herein by reference.
The Registrant makes reference to certain non-GAAP financial
information in the press release. A reconciliation of these non-GAAP financial measures and other financial information is provided
in the press release incorporated herein.
The information furnished under Item 2.02 of this Current Report,
including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be
expressly set forth by specific reference in such filing.
|
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
SENSUS HEALTHCARE, INC.
|
|
|
|
|
Date:
|
May 9, 2019
|
By:
|
/s/ Arthur Levine
|
|
|
|
Arthur Levine
|
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Sep 2023 to Sep 2024